JENNIFER MCDANIEL: Open Payments
NPI 1861784910 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 24 payments from 11 companies in 2025. Trend: 2023 $269 · 2024 $294 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $204 |
| Janssen Biotech, Inc. | 2 | $149 |
| Regeneron Healthcare Solutions, Inc. | 1 | $40 |
| PFIZER INC. | 2 | $32 |
| Ardelyx, Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $23 |
| Braintree Laboratories, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Madrigal Pharmaceuticals | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
Products named: TREMFYA, RINVOQ, DUPIXENT, LINZESS, SKYRIZI, VELSIPITY, IBSRELA, OMVOH.
Industry payments across MO — which companies pay providers there.
